This summary provides useful information for the public on non-alcoholic fatty liver disease (NAFLD), including diagnosis, management, and decision-making processes related to the condition.
A summary of NICE guidance on non-alcoholic fatty liver disease. Includes identification, lifestyle advice, and pharmacological treatment.
A useful and concise summary on the assessment and management of cirrhosis. Recommendations cover diagnosis, monitoring, and managing complications.
This summarises NICE's guideline developed to ensure that more people at increased risk of hepatitis B and C infection are tested.
A summary of the CLDF's Yellow Alert stool chart—for tracking the colour of newborn babies' stools and being alert to warning signs of prolonged jaundice.
Management of hepatic encephalopathy in primary care
Commissioned by Norgine Pharmaceuticals Limited
Date of preparation: October 2017
This management algorithm was developed by a multidisciplinary expert panel: Clayton M et al, and was commissioned by Norgine Pharmaceuticals Limited.
Michelle Clayton examines the current and future impact of liver disease and its causes, and highlights the role of nurses in educating and supporting patients to prevent the disease developing.